Abiopharma

🔍 Becker Dietrich (Director)

Company: Perella Weinberg Partners (PWP)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 968,964 shares of Class A Common Stock (Direct)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,379,452.00 | transaction_form_type: 4
• Sold 968,964 shares of Performance-Based Stock Units (Derivative)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of Class A common stock.
• F2: Each performance-based restricted stock unit ("PSU") represents a contingent right to receive one share of Class A common stock. PSUs vest based on the achievement of (i) service-based vesting conditions that are satisfied in two equal installments on the third and fifth anniversaries of the grant date, subject to a 50% holdback after the first vesting date, and (ii) performance-based vesting conditions that are satisfied upon the achievement, as measured on the last calendar day of each month, of closing stock prices equal to $15, $20, $25 and $30 (subject to linear interpolation) for 20 out of any 30 consecutive trading days, in each case prior to the fifth anniversary of the grant date.
• F3: These PSUs vested on August 31, 2026, upon the achievement of certain service-based and performance-based vesting conditions.